Akèy › Dematit atopik (Ekzema) › Kalifòni › Sacramento
Etid klinik pou Dematit atopik (Ekzema) nan Sacramento, CA
8 etid pou Dematit atopik (Ekzema) ap chèche patisipan nan sit nan ak bò kote Sacramento (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Ap rekriteFaz 2
- Novartis Investigative Site, Sacramento
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Ap rekriteFaz 2
- Integrative Skin Science and Research, Sacramento
Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.
Ap rekriteFaz 4
- Integrative Skin Science and Research, Sacramento
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
Ap rekriteFaz 3
- Integrative Skin Science and Research /ID# 265108, Sacramento
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
Ap rekriteFaz 3
- Leo Pharma Investigational site, Sacramento
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Ap rekriteFaz 3
- Integrative Skin Science and Research /ID# 264537, Sacramento
Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
Ap rekriteFaz 2
- University of California, Davis Health, Department of Dermatology, Sacramento
A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
Ap rekriteFaz 2
- Physioseq, LLC /ID# 267266, Sacramento
Etid Dematit atopik (Ekzema) nan lòt vil
- New York City, NY13 etid
- Los Angeles, CA11 etid
- Washington, DC11 etid
- San Antonio, TX10 etid
- San Diego, CA10 etid
- Birmingham, AL9 etid
- Miami, FL9 etid
- Dallas, TX8 etid
- Huntington Beach, CA8 etid
- Troy, MI8 etid
- Indianapolis, IN7 etid
- Pittsburgh, PA7 etid
Lòt etid nan Sacramento
- Kansè Poumon ki pa ti selil29 etid
- Kansè poumon22 etid
- Kansè nan tete20 etid
- Kansè pwostat19 etid
- Kansè Metastatik16 etid
- Leksemi mieloïd egi12 etid
- Ensifizyans kadyak12 etid
- Kansè pankreyas12 etid
- Kansè (tout kalite)11 etid
- Kansè kolon11 etid
- Kansè vejik10 etid
- Kansè kolorektal10 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.